Evidence map›Paper›PMID 18163495›Full record

ArticleArthritis and rheumatism2008

Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.

Jim C Oates, Stephanie R Shaftman, Sally E Self, Gary S Gilkeson

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. TRIM27 contributes to glomerular endothelial cell injury in lupus nephritis by mediating the FoxO1 signaling pathway.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  7. Article
  8. Article
  9. 1,4-Disubstituted 1International journal of molecular sciences · 2020
    Article
  10. Article
  11. Development of Biomarker Models to Predict Outcomes in Lupus Nephritis.Arthritis & rheumatology (Hoboken, N.J.) · 2016
    Article
  12. Article
  13. Article
  14. Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis.Journal of the American Society of Nephrology : JASN · 2015
    Article
  15. Article
  16. Article
  17. Oxidative stress, T cell DNA methylation, and lupus.Arthritis & rheumatology (Hoboken, N.J.) · 2014
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jim C OatesMedical University of South Carolina, Charleston, South Carolina, USA. oatesjc@musc.edu
Stephanie R Shaftman
Sally E Self
Gary S Gilkeson
Medical University of South Carolina · US

Funding

ZINC AND COPPER METABOLISM IN COLLAGEN DISORDERSM01RR001070 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI REVES, JOSEPH G · 1985 to 2009
$16.3M
Role of reactive intermediates in lupus nephritisR01AR045476 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GILKESON, GARY S, OATES, JAMES C · 1999 to 2012
$3.5M
ROLE OF COMPLEMENT FACTOR B IN THE PATHOGENESIS OF SLER01AI047469 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GILKESON, GARY S. · 2000 to 2004
$1.2M
Role of nitric oxide and eicosanoids in lupus nepthritisK08AR002193 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OATES, JAMES C · 2001 to 2005
$635k
NCRR NIH HHS 5-M01-RR-01070NCRR NIH HHS M01 RR001070NIAID NIH HHS AI-047469NIAID NIH HHS R01 AI047469NIAMS NIH HHS AR-045476NIAMS NIH HHS AR-04745NIAMS NIH HHS K08 AR002193NIAMS NIH HHS K08-AR-002193NIAMS NIH HHS R01 AR045476
6 · The paper itself

Abstract

objectiveReactive intermediate production is an essential component of the innate immune response that is induced during disease activity in murine lupus. This study was undertaken to determine whether a marker of systemic nitric oxide (NO) production correlates with prospectively studied disease activity in human systemic lupus erythematosus (SLE) and lupus nephritis patients.

methodsEighty-three SLE patients and 40 control subjects were studied longitudinally. The SLE group included 23 patients with lupus nephritis documented by renal biopsy and 26 with a history of lupus nephritis. During each visit, following a 24-hour low-nitrate diet, traditional markers of disease activity and damage were determined. Serum nitrate plus nitrite (NOx) levels were determined by chemiluminescence detection.

resultsNOx levels were higher in SLE patients than in controls during the first visit. In univariate longitudinal analyses, NOx levels were associated with SLE Disease Activity Index scores. In multivariate analyses, NOx levels were associated with serum levels of C3 and creatinine and the urinary protein:creatinine ratio. Among patients with lupus nephritis, those with proliferative lesions had higher NOx levels, and higher NOx levels were associated with accumulation of renal damage and lack of response to therapy.

conclusionThis is the first study to prospectively demonstrate longitudinal associations between serum NOx levels and markers of SLE and lupus nephritis disease activity. The more pronounced association with proliferative lupus nephritis and with longitudinal response to lupus nephritis therapy provides a rationale for the study of reactive intermediates as biomarkers of disease activity and therapeutic targets in proliferative lupus nephritis.

Indexed as

AdultBiomarkersBiopsyCross-Sectional StudiesFemaleHumansLongitudinal StudiesLupus Erythematosus, SystemicLupus NephritisMaleMultivariate AnalysisNitratesNitritesSeverity of Illness IndexBiomarkersNitratesNitrites

Identifiers

PMID18163495
PMCPMC2733831
OpenAlexW2033226277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.